印度警方逮捕涉“毒糖浆”企业老板

Core Points - The owner of "Sreyas Pharmaceuticals," Rangnathan, has been arrested in connection with a cough syrup linked to the deaths of at least 21 children under the age of five in Madhya Pradesh [1] - The cough syrup was found to contain diethylene glycol at levels nearly 500 times the permissible limit, which can cause severe health issues and even death [1] - The incident has raised concerns about regulatory failures in India's pharmaceutical industry, with the World Health Organization warning that some affected products may have been exported through informal channels [1][2] Company Summary - "Sreyas Pharmaceuticals" is implicated in a scandal involving a cough syrup that has resulted in multiple child fatalities due to toxic levels of diethylene glycol [1] - The company's facilities in Tamil Nadu have been shut down, and the affected products have been banned in several Indian states [1] - Other pharmaceutical companies in Gujarat have also been found to have similar issues with diethylene glycol in their cough syrups [1] Industry Summary - The incident highlights significant regulatory gaps within India's pharmaceutical sector, prompting local drug regulatory agencies to intensify efforts to control the distribution of contaminated medicines [1] - The World Health Organization is demanding clarification from the Indian government regarding the potential export of these toxic cough syrups, as Indian pharmaceuticals are widely exported to developing countries [2] - The situation has been linked to over 140 child deaths in countries such as Gambia, Uzbekistan, and Cameroon, raising international alarm about the safety of Indian-manufactured drugs [2]